Does Ultrasound-guided Suprascapular Nerve Block Provide Additional Benefit Over Traditional Rehabilitation Program for Patients With Chronic Shoulder Pain

Suprascapular Nerve Block Clinical Trial

— 2015/8/1  

Official title:

Does Ultrasound-guided Suprascapular Nerve Block Provide Additional Benefit

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02776865
• Other study ID #: 2015-09-009C
• Status: Recruiting
• Phase: N/A
• First received: May 16, 2016
• Last updated: May 17, 2016
• Start date: October 2015

Study information

• Verified date: March 2016
• Source: Taipei Veterans General Hospital, Taiwan
• Contact: Jia chi Wang, MD
• Email: jcwang0726[@]gmail.com
• Is FDA regulated: No
• Health authority: Taiwan: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

This study was conducted to compare the efficacy of hydrodilatation with hyaluronic acid under ultrasonographic guidance plus physical therapy (PT) with that of PT alone for treating adhesive capsulitis

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. primary completion date: October 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 40 Years to 80 Years

Eligibility

Inclusion Criteria:

1. chronic shoulder pain with duration of complaints more than 3 months

2. diagnosis of frozen shoulder or rotator cuff disorder

Exclusion Criteria:

1. other conditions involving the shoulder ( rheumatoid arthritis, Hill-Sachs lesions,osteoporosis, or malignancies in the shoulder region);

2. neurologic deficits affecting shoulder function in normal daily activities;

3. shoulder pain caused by cervical radiculopathy

4. a history of drug allergy to xylocaine

5. pregnancy or lactation;

6. received injection into the affected shoulder during the preceding 3 months

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Suprascapular Nerve Block

Intervention

Drug:
• suprascapular nerve block
4ml 2% xylocaine

Other:
• physical therapy
patient received traditional physical therapy, including therapeutic exercise and stretch exercise

Locations

Country	Name	City	State
Taiwan	Taipei veteran general hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
Taipei Veterans General Hospital, Taiwan

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	change in constant shoulder score	the total constant score ranges from 0 to 100 points, with higher scores indicative of better function. The score is divided into four sections: pain, activity of daily living, ROM and strength	at 4, 12 wk	No
Secondary	change in pain intensity	pain intensity was measured by visual analog scale.	at 4, 12 wk	No
Secondary	change in Shoulder Pain And disability index	The Shoulder Pain and Disability Index (SPADI) is a self-administered questionnaire that consists of two dimensions, one for pain and the other for functional activities. The pain dimension consists of five questions regarding the severity of an individual's pain. Functional activities are assessed with eight questions designed to measure the degree of difficulty an individual has with various activities of daily living that require upper-extremity use. The SPADI takes 5 to 10 minutes for a patient to complete and is the only reliable and valid region-specific measure for the shoulder.	at 6, 12 wk	No
Secondary	change in glenohumeral joint range of motion	Shoulder flexion, abduction, external rotation and internal rotation were measured with goniometer with patient in supine position.	at 4, 12 wk	No